VASH1 and neoplasm: At the same time, we found that VASH1 has a clear correlation with TMB in LGG, so we believe that VASH1 can be used as a potential immunotherapy target and reflect the ability and extent of tumor production of neoantigens, predicting the immunotherapy efficacy of LGG.